Variant report
Variant | esv1830364 |
---|---|
Chromosome Location | chr8:58175432-58198163 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:34)
- CpG islands (count:915)
- Chromatin interactive region (count:1)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:34 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr8:58189904-58189917 | GM12878 | blood: | n/a | n/a |
2 | E2F4 | chr8:58180057-58180448 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOXA1 | chr8:58185630-58185995 | HepG2 | liver: | n/a | n/a |
4 | FOXA1 | chr8:58185559-58185945 | HepG2 | liver: | n/a | n/a |
5 | FOXA1 | chr8:58185554-58185908 | HepG2 | liver: | n/a | n/a |
6 | FOXA1 | chr8:58185005-58185328 | HepG2 | liver: | n/a | n/a |
7 | FOXA1 | chr8:58185011-58185376 | HepG2 | liver: | n/a | n/a |
8 | FOXA1 | chr8:58184986-58185275 | HepG2 | liver: | n/a | n/a |
9 | FOXA1 | chr8:58185585-58186018 | HepG2 | liver: | n/a | n/a |
10 | FOXA1 | chr8:58184959-58185448 | HepG2 | liver: | n/a | n/a |
11 | FOXA2 | chr8:58185598-58185963 | HepG2 | liver: | n/a | n/a |
12 | FOXA2 | chr8:58185083-58185214 | HepG2 | liver: | n/a | n/a |
13 | GATA3 | chr8:58178195-58178384 | SH-SY5Y | brain: | n/a | n/a |
14 | HNF4A | chr8:58185651-58185977 | HepG2 | liver: | n/a | chr8:58185776-58185791 |
15 | HNF4A | chr8:58185594-58185923 | HepG2 | liver: | n/a | chr8:58185776-58185791 |
16 | JUND | chr8:58188570-58188850 | HepG2 | liver: | n/a | chr8:58188723-58188732 |
17 | MAFF | chr8:58178089-58178110 | K562 | blood: | n/a | n/a |
18 | MAFK | chr8:58185844-58186135 | HepG2 | liver: | n/a | chr8:58185987-58186003 |
19 | MAFK | chr8:58185918-58186121 | HepG2 | liver: | n/a | chr8:58185987-58186003 |
20 | MXI1 | chr8:58178391-58178470 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chr8:58185280-58185372 | Gliobla | brain: | n/a | n/a |
22 | POLR2A | chr8:58185419-58185465 | Gliobla | brain: | n/a | n/a |
23 | POLR2A | chr8:58190837-58190839 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr8:58195607-58195807 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | POLR2A | chr8:58191039-58191090 | MCF-7 | breast: | n/a | n/a |
26 | POLR2A | chr8:58181694-58181852 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | RXRA | chr8:58185647-58185890 | HepG2 | liver: | n/a | n/a |
28 | SP1 | chr8:58185549-58185935 | HepG2 | liver: | n/a | n/a |
29 | SPI1 | chr8:58182022-58182209 | K562 | blood: | n/a | n/a |
30 | SPI1 | chr8:58182021-58182222 | GM12878 | blood: | n/a | n/a |
31 | SPI1 | chr8:58182022-58182219 | GM12891 | blood: | n/a | n/a |
32 | STAT3 | chr8:58179999-58180198 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | YY1 | chr8:58185690-58185963 | HepG2 | liver: | n/a | n/a |
34 | YY1 | chr8:58185652-58185912 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:58190903-58190953 | HCPEpiC | choroid plexus: | n/a |
2 | chr8:58190903-58190953 | Hela-S3 | cervix: | n/a |
3 | chr8:58193284-58193334 | ovcar-3 | ovarian: | n/a |
4 | chr8:58191956-58192006 | AoSMC | blood vessel: | n/a |
5 | chr8:58192021-58192071 | U87 | brain: | n/a |
6 | chr8:58188909-58188959 | NB4 | blood: | n/a |
7 | chr8:58192065-58192115 | ECC-1 | luminal epithelium: | n/a |
8 | chr8:58193284-58193334 | HNPCEpiC | eye: | n/a |
9 | chr8:58177661-58177711 | HepG2 | liver: | n/a |
10 | chr8:58191956-58192006 | CMK | blood: | n/a |
11 | chr8:58192502-58192552 | SK-N-SH_RA | brain: | n/a |
12 | chr8:58192753-58192803 | LNCaP | prostate: | n/a |
13 | chr8:58191952-58192002 | PANC-1 | pancreas: | n/a |
14 | chr8:58191956-58192006 | ProgFib | skin: | n/a |
15 | chr8:58188909-58188959 | U87 | brain: | n/a |
16 | chr8:58192753-58192803 | GM12892 | blood: | n/a |
17 | chr8:58193284-58193334 | A549 | lung: | n/a |
18 | chr8:58192883-58192933 | ProgFib | skin: | n/a |
19 | chr8:58192502-58192552 | PANC-1 | pancreas: | n/a |
20 | chr8:58188909-58188959 | HCT-116 | colon: | n/a |
21 | chr8:58192753-58192803 | NB4 | blood: | n/a |
22 | chr8:58188909-58188959 | IMR90 | lung: | fetal |
23 | chr8:58193284-58193334 | Hela-S3 | cervix: | n/a |
24 | chr8:58192502-58192552 | GM12891 | blood: | n/a |
25 | chr8:58191956-58192006 | GM06990 | blood: | n/a |
26 | chr8:58191910-58191960 | IMR90 | lung: | fetal |
27 | chr8:58177661-58177711 | HMEC | breast: | n/a |
28 | chr8:58192883-58192933 | HMEC | breast: | n/a |
29 | chr8:58193284-58193334 | GM06990 | blood: | n/a |
30 | chr8:58191386-58191436 | BE2_C | brain: | n/a |
31 | chr8:58192021-58192071 | HUVEC | blood vessel: | n/a |
32 | chr8:58177661-58177711 | AG04450 | lung: | fetal |
33 | chr8:58192502-58192552 | PFSK-1 | brain: | n/a |
34 | chr8:58191952-58192002 | GM12891 | blood: | n/a |
35 | chr8:58192883-58192933 | HNPCEpiC | eye: | n/a |
36 | chr8:58192753-58192803 | HEK293 | kidney: | embryo |
37 | chr8:58192883-58192933 | PrEC | prostate: | n/a |
38 | chr8:58192065-58192115 | IMR90 | lung: | fetal |
39 | chr8:58193284-58193334 | PrEC | prostate: | n/a |
40 | chr8:58193284-58193334 | PFSK-1 | brain: | n/a |
41 | chr8:58192502-58192552 | MCF10A-Er-Src | breast: | n/a |
42 | chr8:58188909-58188959 | HCF | heart: | n/a |
43 | chr8:58188909-58188959 | SK-N-SH | brain: | n/a |
44 | chr8:58177661-58177711 | SK-N-SH_RA | brain: | n/a |
45 | chr8:58191386-58191436 | AG09309 | skin: | n/a |
46 | chr8:58192883-58192933 | AG04450 | lung: | fetal |
47 | chr8:58191956-58192006 | HMEC | breast: | n/a |
48 | chr8:58192021-58192071 | T-47D | breast: | n/a |
49 | chr8:58192021-58192071 | PANC-1 | pancreas: | n/a |
50 | chr8:58191610-58191660 | HNPCEpiC | eye: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:58190918..58193705-chr8:58197368..58198890,2 | K562 | blood: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM110B-7 | chr8:58174093-58175676 | NR_038874 |
2 | lnc-FAM110B-7 | chr8:58174093-58175676 | ENSG00000253614 |
3 | lnc-FAM110B-7 | chr8:58177900-58179172 | ENSG00000253614 |
4 | lnc-FAM110B-7 | chr8:58177900-58179170 | NR_038874 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-596P | TF binding region |
LINC00588 | TF binding region |
RNU6-596P | CpG island |
LINC00588 | CpG island |
ENSG00000215117 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201151077 | chr8:58175458-58175459 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs201470302 | chr8:58175463-58175464 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs372680419 | chr8:58175464-58175465 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs190985589 | chr8:58175546-58175547 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs558223755 | chr8:58175589-58175590 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs56740825 | chr8:58175617-58175618 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs537696960 | chr8:58175619-58175620 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs536248579 | chr8:58175659-58175660 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs533588606 | chr8:58177939-58177940 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs554088972 | chr8:58177963-58177964 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs577255190 | chr8:58177988-58177989 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs67895971 | chr8:58177994-58177995 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs146969420 | chr8:58178042-58178043 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs186673812 | chr8:58178094-58178095 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs147713571 | chr8:58178132-58178133 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs56350499 | chr8:58178139-58178140 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs561239152 | chr8:58178140-58178141 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs552586548 | chr8:58178207-58178208 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs530088502 | chr8:58178238-58178239 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs56255635 | chr8:58178264-58178265 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs191337338 | chr8:58178275-58178276 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs572136774 | chr8:58178278-58178279 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs532625711 | chr8:58178280-58178281 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs552456135 | chr8:58178306-58178307 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs539159724 | chr8:58178311-58178312 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs569408179 | chr8:58178313-58178314 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs531829792 | chr8:58178318-58178319 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs548253125 | chr8:58178389-58178390 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs568093362 | chr8:58178447-58178448 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs533765820 | chr8:58178464-58178465 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs149221824 | chr8:58178477-58178478 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs375800941 | chr8:58178478-58178479 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs200305601 | chr8:58178490-58178491 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs200782114 | chr8:58178494-58178495 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs55787104 | chr8:58178519-58178520 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs185046718 | chr8:58178520-58178521 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs112807649 | chr8:58178570-58178571 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs149196170 | chr8:58178577-58178578 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs556518404 | chr8:58178621-58178622 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs576151544 | chr8:58178633-58178634 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs116256104 | chr8:58178639-58178640 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs148377719 | chr8:58178655-58178656 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs377157311 | chr8:58178661-58178662 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs370668813 | chr8:58178662-58178663 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs201151452 | chr8:58178665-58178666 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs373033219 | chr8:58178668-58178669 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs574877814 | chr8:58178702-58178703 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs141393618 | chr8:58178722-58178723 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs187882984 | chr8:58178729-58178730 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs576849437 | chr8:58178780-58178781 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:58185200-58185400 | Enhancers | HepG2 | liver |
2 | chr8:58185400-58185800 | Enhancers | Pancreas | Pancrea |
3 | chr8:58185400-58185800 | Flanking Active TSS | HepG2 | liver |
4 | chr8:58185600-58187200 | Enhancers | Fetal Lung | lung |
5 | chr8:58185800-58186600 | Enhancers | HepG2 | liver |
6 | chr8:58187600-58187800 | Enhancers | Aorta | Aorta |
7 | chr8:58190800-58193000 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr8:58191000-58192400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
9 | chr8:58191200-58191400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr8:58191400-58191600 | Flanking Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr8:58191400-58193000 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin02 | Skin |
12 | chr8:58191600-58193400 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr8:58192200-58192400 | Bivalent Enhancer | Skeletal Muscle Female | skeletal muscle |
14 | chr8:58192400-58192800 | Flanking Bivalent TSS/Enh | Fetal Muscle Trunk | muscle |
15 | chr8:58192400-58193600 | Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr8:58192600-58192800 | Enhancers | Muscle Satellite Cultured Cells | -- |
17 | chr8:58192600-58192800 | Bivalent/Poised TSS | Fetal Brain Female | brain |
18 | chr8:58192600-58192800 | Bivalent/Poised TSS | Skeletal Muscle Male | skeletal muscle |
19 | chr8:58192600-58193200 | Active TSS | Cortex derived primary cultured neurospheres | brain |
20 | chr8:58192800-58193000 | Active TSS | Fetal Brain Female | brain |
21 | chr8:58192800-58193000 | Flanking Active TSS | Fetal Muscle Trunk | muscle |
22 | chr8:58193000-58193400 | Active TSS | Fetal Muscle Trunk | muscle |
23 | chr8:58193200-58193400 | Flanking Active TSS | Cortex derived primary cultured neurospheres | brain |
24 | chr8:58193400-58193800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
25 | chr8:58196800-58197200 | Enhancers | Fetal Brain Female | brain |
26 | chr8:58197000-58197200 | Enhancers | Fetal Lung | lung |